Search

everythinglearnresearchcommunity

for

Search:↓

Researchers found that certain miRNAs, which affect immune system regulation, are differently expressed in mice with a hair loss condition compared to healthy mice.

IL-17 is more important than IFN-γ in causing severe hair loss in chronic alopecia areata.

The surrounding tissue plays a crucial role in the growth and spread of skin cancer.

Giving immune serum from vaccinated mice to mice without T cells prevents infection and tumor growth.

The growth of the Epstein-Barr virus in the patient's cells was linked to the worsening of her lymphoma.

The document concludes that choosing the right biopsy site is crucial for accurate alopecia diagnosis, and combining methods can improve results.

Alopecia areata is an autoimmune disorder causing hair loss, linked to specific hair follicle antigens and genetic factors.

Dermatologists give better information on pathology forms, hypersensitivity vasculitis is a common skin issue, misdiagnoses can occur, and various skin conditions are linked to loss of elastin or genetic factors.

Innate lymphoid cells type 1 may contribute to alopecia areata.

A patient with leukemia/lymphoma also had multiple autoimmune diseases, suggesting a link between them.

The skin can independently form immune responses through special structures, offering new ways to treat skin diseases.

Clonally expanded CD8+ T cells cause alopecia areata.

DM and AA may share a common cause.

Monoclonal antibody B72.3 selectively reacts with certain dog tissues, mainly in the gastrointestinal and respiratory tracts.

Genetic variants linked to ten skin diseases were found, showing both immune and non-immune factors play a role.

PD‐L1 and PD‐L2 may not effectively control immune activation in alopecia areata.

BAFF-targeted therapies can reduce autoimmune disease activity, but more research is needed for precise treatments.

Psoriasis involves an imbalance between certain immune cells, and targeting these could help restore skin health.

Targeted immunotherapy could be a promising new treatment for hair regrowth.

Interferons are effective for some skin conditions and cancers, but can have side effects and need more research for optimal use.

Melanocyte-associated antigens may play a key role in alopecia areata and could be targets for new treatments.

IFN-γ and IL-2 are important for T cell activation in hair loss in mice.

Abnormal ECM and immune cell interactions can cause skin diseases.

Monoclonal antibodies LT-1, LT-2, and LT-7 help diagnose certain blood cancers.

Netherton syndrome has two subtypes with shared immune traits but different allergic and immune responses, suggesting targeted treatments.

Certain natural and synthetic compounds may help treat inflammatory skin diseases by targeting a specific signaling pathway.

In alopecia areata, certain immune cells increase and express a protein linked to immune activation.

The conclusion is that a new method could improve the identification of autoimmune targets in alopecia areata, despite some limitations.

The new skin model can predict how chemicals might cause skin allergies.

Alopecia areata patients have more activated T cells in their blood, which may help in developing treatments.